K-161

· Kowa Research Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for K-161, covering 2023-03-15 to 2023-03-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease [Phase 2]

See pricing